SlideShare a Scribd company logo
NOT FOR U.S. AND CANADA AUDIENCE
Randy Wilkins
Principal Technical Consultant
2
• “Retesting is just a routine part of the process”
- The best option for troubleshooting is to not have to do it in
the first place
- Webinar: Filter Integrity Testing Best Practices
http://bit.ly/2jEKlEm
• “Filters always fail because they are not wet properly”
- Poor wetting is a reason, but far from the only reason
- Ignoring other potential failure modes result in lost time,
product and frustration
Integrity Testing Myths
3
• “Retesting is just a routine part of the process”
- The best option for troubleshooting is to not have to do it in
the first place
- Webinar: Filter Integrity Testing Best Practices
http://bit.ly/2jEKlEm
• “Filters always fail because they are not wet properly”
- Poor wetting is a reason, but far from the only reason
- Ignoring other potential failure modes result in lost time,
product and frustration
• “You are only allowed to re-test the filter twice”
- You can’t simply retest until you get the answer you want
- Why impose a limit?
- If the reason for a failed/invalid test is clear and
documented, why limit the option for a re-test?
Integrity Testing Myths
4
Demystifying Integrity Test Filters
Understanding the possible causes of IT failures
Being able to apply a logical step-by-step re-test procedure to distinguish between a
false failure and a real failure
Developing internal trouble shooting SOP to establish the root cause of IT failures
After today’s session you will be able to improve your internal IT process by:
5
Integrity Test Review
Integrity tests are based on capillary forces that hold liquid in the pores of wet membranes. Liquid in the
pores of the membrane are a barrier to bulk gas flow. The smaller the pores, the stronger the capillary
forces.
4 . k .  . cos 
BP = -----------------
d
• k = shape correction factor
• = surface tension
• = contact angle
• d = pore diameter
Bubble Point Test
K . (P1 - P2) . A . 
Diffusion = --------------------
L
K = Diffusivity / Solubility coefficient
P1, P2 = Pressure difference
across the system
= Membrane porosity
L = Effective path length
A = Membrane area
Diffusion Test
5
Integrity Test Review – Diffusion
 Liquid is held in the pores of a fully wetted membrane filter by
capillary forces
 A pressure differential will give a gas concentration gradient across
the filter.
 Results in diffusive gas flow from upstream to downstream.
Wet membrane
Apply pressure
from validated
specification
Hold pressure
6
7
Integrity Test Review - Diffusion
Gas flow rate within specification indicates flow is solely
from diffusion, which indicates the absence of defects or
over sized pores.
Out of specification
GasFlow
Within
specification
Pressure
Bad filter
Good
filter
Measure the
gas flow rate
Integrity Test Review – Bubble Point
8
Out of
specification
Within
specification
GasFlow
Pressure
Durapore®
CVGL:
50psid
Good
filter
Bad filter
Wet Membrane
 Water is held in the pores by
capillary force
Gradually raise
pressure
 Sufficient pressure will
overcome capillary forces and
push liquid from the filter
Determine pressure
were onset of bulk
flow is observed
 The smaller the pores, the
higher the bubble point
pressure
Integrity Test Review – Automated Testing
9
All else being constant, the change in pressure
can be used to determine the gas flow rate
1
During integrity testing gas molecules flow
through the filter and leave the system
2
Fewer gas molecules upstream result in lower
pressure
3
Upstream Pressurized
Compressed gas
Gas flow
Potential Results – General Categories
• What are potential results?
10-inch Durapore® filter specifications
Bubble point ≥50 psi
Diffusion ≤ 13.3 cc/min at 40 psi
GasFlow
Pressure
Diffusion spec
Bubble Point spec.
10
Potential Results – General Categories
GasFlow
Pressure
Diffusion spec
Bubble Point spec.
PASS
• What are potential results?
10-inch Durapore® filter specifications
Bubble point ≥50 psi
Diffusion ≤ 13.3 cc/min at 40 psi
Example 1 - PASS
BP = 55 psi
Diffusion = 10 cc/min
11
Potential Results – General Categories
• What are potential results?
10-inch Durapore® filter specifications
Bubble point ≥50 psi
Diffusion ≤ 13.3 cc/min at 40 psi
Example 1 - PASS
BP = 55 psi
Diffusion = 10 cc/min
Example 2 – Marginal Failure
BP = 48 psi
Diffusion = 20 cc/min
GasFlow
Pressure
Diffusion spec
Bubble Point spec.
PASS
Marginal failure
12
Potential Results – General Categories
• What are potential results?
10-inch Durapore® filter specifications
Bubble point ≥50 psi
Diffusion ≤ 13.3 cc/min at 40 psi
Example 1 - PASS
BP = 55 psi
Diffusion = 10 cc/min
Example 2 – Marginal Failure
BP = 48 psi
Diffusion = 20 cc/min
Example 3 - Gross Failure
BP < 5psi
GasFlow
Pressure
Diffusion spec
Bubble Point spec
PASS
Marginal failureGross failure
13
Potential Results – General Categories
• What are potential results?
10-inch Durapore® filter specifications
Bubble point ≥50 psi
Diffusion ≤ 13.3 cc/min at 40 psi
Example 1 - PASS
BP = 55 psi
Diffusion = 10 cc/min
Example 2 – Marginal Failure
BP = 48 psi
Diffusion = 20 cc/min
Example 3 - Gross Failure
BP < 5psi
Example 4 - Invalid Test
BP > 75 psi
Diffusion = 0 cc/min
GasFlow
Pressure
Diffusion spec
Bubble Point spec.
PASS
Marginal failureGross failure
Invalid
14
A Good Troubleshooting SOP is Essential
A well written, properly executed
troubleshooting SOP should answer two
questions:
1. Is the filter integral or not?
2. Why did the test fail in the first place?
15
SOP Development – What can go wrong?
Flow and Pressure Wetting Limits
0
10
20
30
40
50
60
0 0.2 0.4 0.6 0.8 1
Flow Rate (lpm/ft^2)
Pressure(psi)
INTEGRITY TEST PASS ZONE
INTEGRITY TEST
FALSE FAILURE ZONE
Recommended
Wetting
Conditions
16
1. Poor wetting
SOP Development – What can go wrong?
17
1.
2.
Poor wetting
Wrong test program
SOP Development – What can go wrong?
18
1.
2.
3.
Poor wetting
Wrong test program
Wrong filter used
SOP Development – What can go wrong?
19
1.
2.
3.
4.
Poor wetting
Wrong test program
Wrong filter used
Improper seals
SOP Development – What can go wrong?
20
1.
2.
3.
4.
5.
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
SOP Development – What can go wrong?
21
1.
2.
3.
4.
5.
6.
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
4 . k .  . cos 
BP = -------------------------
d
• k = shape correction factor
• = surface tension
• = contact angle
• d = pore diameter
Bubble Point Test
SOP Development – What can go wrong?
22
1.
2.
3.
4.
5.
6.
7.
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Wrong test gas
K . (P1 - P2) . A . 
Diffusion = ---------------------
L
K = Diffusivity / Solubility coefficient
P1, P2 = Pressure difference
across the system
= Membrane porosity
L = Effective path length
A = Membrane area
Diffusion Test
SOP Development – What can go wrong?
23
z
1.
2.
3.
4.
5.
6.
7.
8.
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
SOP Development – What can go wrong?
24
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Stable Temperature Environment
Manufacturers specifications are typically established at ambient
temperature (~23°C)
If operating outside of ambient temperature, a ratio should be
established during validation and applied to test specification
- e.g., Cold room operation or heat jacketed housing
Effect of Tem perature on Diffusional Flow rate
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
5 10 15 20 25 30 35 40 45 50 55 60 65 70
Tem perature (C)
CorrectionFactor(Relative
to23C)
There is no significant impact on diffusive flow or BP
over normal ambient temperature range
1
2
25
Stable Temperature Environment
Within
Specification
Out of
Specification
AirFlow
ml/min
Time min
Test has to be repeated per retest SOP after
establishing stable test conditions
Apparent Gas Flow
Trained operator can identify the temperature effect by
reviewing the flow curve
Common reasons for temperature changes
 Inadequate stabilization after steaming or wetting
with hot WFI
 Environmental changes during testing near
autoclave, HVAC outlets, cold room door, near a
window, etc.
 When using Automatic Testers, temperature changes
during a test leads to additional upstream pressure
gain or loss – Test Error
 Idea Gas Law – PV=nRT
 As Temperature increases, Pressure increases
 As Temperature decreases, Pressure decreases
 Even a change of 1 C DURING the test can lead
to false failure because the pressure change
WILL NOT be solely due to gas flow
26
Flow at
unstable temp
False failure
Flow at stable
temp
SOP Development – What can go wrong?
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
27
Common causes for surface tension
suppression:
Residual Product: Develop product based on
integrity test specification and post-use flush
procedure
Application Note
AN1505EN00
SOP Development – What can go wrong?
28
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
10
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
Common causes for surface tension
suppression:
• Contaminants: New silicone tubing, residual
cleaning agent, etc.
- Identify and eliminate
Freon residue - silicone rubber Millidisk minus body oil
Silicone oil
100020003000
cm-¹
SOP Development – What can go wrong?
29
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
10
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
Common causes for surface tension
suppression:
• Contaminants: New silicone tubing, residual
cleaning agent, etc.
- Identify and eliminate
Impact of tubing material on the failure of product-specific bubble points of
sterilizing grade-filters Meyer and Vargas, PDA Journal of Parenteral
Science, Vol 60 n°4 2006
SOP Development – What can go wrong?
30
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
10
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
11. Damaged O-rings
SOP Development – What can go wrong?
31
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
10
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
11.
12.
Damaged O-rings
Instrument calibration
SOP Development – What can go wrong?
32
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
10
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
11.
12.
13.
Damaged O-rings
Instrument calibration
Air lock
SOP Development – What can go wrong?
33
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
10
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
11.
12.
13.
Damaged O-rings
Instrument calibration
Air lock
NOTE: This is not an exhaustive list.
Consider developing a site-specific list by
conducting a brainstorming session with the
people routinely performing the integrity
test.
SOP Development – What can go wrong?
34
Pass
Fail
Initial Test
Wet at 1 LPM/0.1 m2 filter area
SOP Development
35
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
11.
12.
13.
Damaged O-rings
Instrument calibration
Air lock
Evaluate test results
Verify system set-up and test
parameters
Evaluate Test Results
36
36
Stable flow
Clear BP
Good test
Stable flow
Shifted up
Possible leak
Non-stable flow
Likely temp
change
Troubleshooting Flow Chart Development
37
Pass
Set up or
Execution
problem
identified
and
corrected
Fail
Initial Test
Wet at 1 LPM/0.1 m2 filter
area
Check test
set-up and
execution
Test set-up
and
execution
verified
correct
SOP Development
38
z
1.
2.
3.
4.
5.
6.
7.
8.
9.
10
Poor wetting
Wrong test program
Wrong filter used
Improper seals
Damaged filter
Wrong wetting fluid
Leaks (housing, tubing, integrity tester)
Wrong test gas
Temperature change
Surface tension suppression
11.
12.
13.
Damaged O-rings
Instrument calibration
Air lock
Remaining potential
failure modes require
re-test.
Rewet Options
Wetting Option Ease of Implementation Failure Modes Addressed Failure Modes Not Addressed
Longer Time Easy
Poor wetting, non-adsorbed
surface active residuals
Damage, Air Lock, adsorbed
surface active contaminants
Warm Water Flush Easy if facilities are available
Poor wetting, non-adsorbed
water soluble surface active
residuals
Damage, Air lock, adsorbed
surface active residuals
Higher Flow Rate
Easy depending on system
capabilities
Poor wetting, non-adsorbed
surface active residuals
Damage, Air Lock, adsorbed
surface active contaminants
Higher System Pressure Easy
Poor Wetting, non-adsorbed
surface active residuals,
Damage, Air lock, adsorbed
surface active residuals
Alcohol
Complex when alcohol
contamination in the process is a
risk
Poor wetting, non-adsorbed
surface active residuals,
adsorbed surface active
residuals,
Damage, severe air lock
39
Pressure Wetting
Standard Wetting
inlet
0
outlet
2
For 0.22 m Durapore® filter devices at 1 lpm/0.1 m2
Inlet pressure = 2 psi/0.14 bar
Outlet pressure = 0 psi/0 bar
p = 2 psi/0.14 bar
High Pressure Wetting
inlet
38
outlet
40
High Pressure Wetting at 1 lpm/0.1 m2
Inlet pressure = 40 psi/2.7 bar
Outlet pressure = 38 psi/2.6 bar
p = 2 psi/0.14 bar
40
Rewet Options
Wetting Option Ease of Implementation Failure Modes Addressed Failure Modes Not Addressed
Longer Time Easy
Poor wetting, non-adsorbed
surface active residuals
Damage, Air Lock, adsorbed
surface active contaminants
Warm Water Flush Easy if facilities are available
Poor wetting, non-adsorbed
water soluble surface active
residuals
Damage, Air lock, adsorbed
surface active residuals
Higher Flow Rate
Easy depending on system
capabilities
Poor wetting, non-adsorbed
surface active residuals
Damage, Air Lock, adsorbed
surface active contaminants
Higher System Pressure Easy
Poor Wetting, non-adsorbed
surface active residuals,
Damage, Air lock, adsorbed
surface active residuals
Alcohol
Complex when alcohol
contamination in the process is a
risk
Poor wetting, non-adsorbed
surface active residuals,
adsorbed surface active
residuals,
Damage, severe air lock
41
First Retest – High Pressure Wet
inlet
38
outlet
40
42
Pass
Consider poor wetting
as cause of initial test
failure
Fail
First Re-test
Wet at 1 LPM/0.1 m2 filter area with
back pressure
Second Retest – Alcohol Wet
43
Pass
Consider presence of
surface active
compounds as the
cause of initial test
failure
Fail
Second Re-test
Wet and test with 70/30 IPA
43
Third Retest – Dry and Re-wet with water
4444
Pass
Initial failures likely due
to air lock
Fail
Dry with dynamic air flow or
oven drying at 80 C for 8 hrs
Wet and test with water
Contact filter vendor for
confirmation and defect analysis
Summary
• When failing integrity test results occur,
consider all the potential failure causes
- Many are common, some may be site
specific
• Develop a troubleshooting flowchart based
on understanding of failure modes and
remedies
• Conclusions about failure modes may not
be definitive
- A logical approach will yield the best
assessment of failure mode
- Best assessment will yield justification for
re-tests and direction for corrective
actions
45
Additional TroubleshootingAdditional Troubleshooting - PDA 26
46
The 2008 revision includes an excellent trouble-shooting flowchart
Thank You.
Questions?
47

More Related Content

What's hot

Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Merck Life Sciences
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
MilliporeSigma
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Merck Life Sciences
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
MilliporeSigma
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)
Merck Life Sciences
 
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
MilliporeSigma
 
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
Merck Life Sciences
 
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
Merck Life Sciences
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
Merck Life Sciences
 
STERILE PROCESS OF VALIDATION
STERILE PROCESS OF VALIDATIONSTERILE PROCESS OF VALIDATION
STERILE PROCESS OF VALIDATION
Sagar Savale
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
Merck Life Sciences
 
FDA Guidance on Facing Sterile Manufacturing Inspections.
FDA Guidance on Facing Sterile Manufacturing  Inspections.FDA Guidance on Facing Sterile Manufacturing  Inspections.
FDA Guidance on Facing Sterile Manufacturing Inspections.
GMP EDUCATION : Not for Profit Organization
 
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeSingle-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Merck Life Sciences
 
Cleanroom Qualification
Cleanroom QualificationCleanroom Qualification
Cleanroom Qualification
Anwar Munjewar
 
Validation Protocol
Validation ProtocolValidation Protocol
Validation Protocol
Sagar Savale
 
Temperature Mapping (WHO).pdf
Temperature Mapping (WHO).pdfTemperature Mapping (WHO).pdf
Temperature Mapping (WHO).pdf
Dr.Noor Nabi Lodhi
 
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Merck Life Sciences
 
Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...
Merck Life Sciences
 
Validation of membrane filter
Validation of membrane filterValidation of membrane filter
Validation of membrane filter
Sagar Savale
 

What's hot (20)

Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
 
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...Selection, sizing, and operation of bioprocess filtration trains for optimal ...
Selection, sizing, and operation of bioprocess filtration trains for optimal ...
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)
 
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
 
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
An Efficient and cGMP-friendly Solution to Diafiltration for Intensified or C...
 
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
EU GMP Annex 1 – Implications on Filtration and Single Use Technology by Soma...
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
 
STERILE PROCESS OF VALIDATION
STERILE PROCESS OF VALIDATIONSTERILE PROCESS OF VALIDATION
STERILE PROCESS OF VALIDATION
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
 
FDA Guidance on Facing Sterile Manufacturing Inspections.
FDA Guidance on Facing Sterile Manufacturing  Inspections.FDA Guidance on Facing Sterile Manufacturing  Inspections.
FDA Guidance on Facing Sterile Manufacturing Inspections.
 
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeSingle-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
 
Cleanroom Qualification
Cleanroom QualificationCleanroom Qualification
Cleanroom Qualification
 
Validation Protocol
Validation ProtocolValidation Protocol
Validation Protocol
 
Temperature Mapping (WHO).pdf
Temperature Mapping (WHO).pdfTemperature Mapping (WHO).pdf
Temperature Mapping (WHO).pdf
 
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
 
Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...Bioburden control: Strategies to address bioburden control in downstream proc...
Bioburden control: Strategies to address bioburden control in downstream proc...
 
Validation of membrane filter
Validation of membrane filterValidation of membrane filter
Validation of membrane filter
 
CLEANING VALIDATION-NS
CLEANING VALIDATION-NSCLEANING VALIDATION-NS
CLEANING VALIDATION-NS
 

Viewers also liked

The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
Merck Life Sciences
 
The Comprehensive Guide to Genotoxicity Assessment
The Comprehensive Guide to Genotoxicity AssessmentThe Comprehensive Guide to Genotoxicity Assessment
The Comprehensive Guide to Genotoxicity Assessment
Merck Life Sciences
 
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and InnovationsSerum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Merck Life Sciences
 
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Merck Life Sciences
 
Venture Capital Funding: An Insider’s View
Venture Capital Funding: An Insider’s ViewVenture Capital Funding: An Insider’s View
Venture Capital Funding: An Insider’s View
Merck Life Sciences
 
Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer 
Merck Life Sciences
 
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Merck Life Sciences
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
Merck Life Sciences
 
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Merck Life Sciences
 
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic TherapeuticsRapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Merck Life Sciences
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Merck Life Sciences
 
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Merck Life Sciences
 
Cells Powerpoint Presentation
Cells Powerpoint PresentationCells Powerpoint Presentation
Cells Powerpoint Presentationcprizel
 

Viewers also liked (13)

The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
The Role of BPOG Extractables Data in the Effective Adoption of Single-Use Sy...
 
The Comprehensive Guide to Genotoxicity Assessment
The Comprehensive Guide to Genotoxicity AssessmentThe Comprehensive Guide to Genotoxicity Assessment
The Comprehensive Guide to Genotoxicity Assessment
 
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and InnovationsSerum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
Serum-free Media for Therapeutic Cell Manufacturing – Challenges and Innovations
 
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
Considerations for Manufacturing Commercial Antibody Drug Conjugates (ADCs) -...
 
Venture Capital Funding: An Insider’s View
Venture Capital Funding: An Insider’s ViewVenture Capital Funding: An Insider’s View
Venture Capital Funding: An Insider’s View
 
Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer 
 
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
Time is of the Essence: Creating a New Synergy Between Single-Use Adopters an...
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
 
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
 
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic TherapeuticsRapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
 
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
Viral Risk Mitigation Strategies: Key Considerations in the Prevention and De...
 
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
Delivering More Efficient Therapeutic Protein Expression Systems Through Cell...
 
Cells Powerpoint Presentation
Cells Powerpoint PresentationCells Powerpoint Presentation
Cells Powerpoint Presentation
 

Similar to Integrity Test Troubleshooting – Beyond Rewet and Retest

Hplc troubleshooting converted
Hplc troubleshooting convertedHplc troubleshooting converted
Hplc troubleshooting converted
RAVINDRABABUKOPPERA
 
hplc class.ppt
hplc class.ppthplc class.ppt
hplc class.ppt
WaheedAhmad960679
 
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNETItem 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
ExternalEvents
 
M epockete nf
M epockete nfM epockete nf
M epockete nf
GuilhermeGuimares77
 
Automating Leak Testing
Automating Leak TestingAutomating Leak Testing
Automating Leak Testing
Elizabeth (Lisa) Gardner
 
Technology reqmts-hvac-design-ses-2-aseptic-wkshp-pune-f
Technology reqmts-hvac-design-ses-2-aseptic-wkshp-pune-fTechnology reqmts-hvac-design-ses-2-aseptic-wkshp-pune-f
Technology reqmts-hvac-design-ses-2-aseptic-wkshp-pune-f
sachin kumar
 
07 wtp design 2
07 wtp design 207 wtp design 2
07 wtp design 2
Soumen Basu
 
Suncombe cip overview presentation
Suncombe cip overview presentationSuncombe cip overview presentation
Suncombe cip overview presentation
Kyriakos Michalaki
 
PPT-on-false-air.ppt
PPT-on-false-air.pptPPT-on-false-air.ppt
PPT-on-false-air.ppt
vikramparuthi1
 
Final Review Elaine Mau Procter and Gamble
Final Review Elaine Mau Procter and GambleFinal Review Elaine Mau Procter and Gamble
Final Review Elaine Mau Procter and GambleElaine Mau
 
Air Duct Leakage
Air Duct LeakageAir Duct Leakage
Air Duct Leakage
Mostafa Al Wakeel
 
Hydrant flushing programs
Hydrant flushing programsHydrant flushing programs
Hydrant flushing programs
Brian Gongol
 
validation-of-sterilising-and-virally-retentive-filters.pdf
validation-of-sterilising-and-virally-retentive-filters.pdfvalidation-of-sterilising-and-virally-retentive-filters.pdf
validation-of-sterilising-and-virally-retentive-filters.pdf
Md. Omar Faruq Khan
 
Troubleshooting of Distillation
Troubleshooting of DistillationTroubleshooting of Distillation
Troubleshooting of Distillation
Marcep Inc.
 
Control valve presentation
Control valve presentationControl valve presentation
Control valve presentation
Prem kumar
 
Clean In Place - Cycle Development
Clean In Place - Cycle DevelopmentClean In Place - Cycle Development
Clean In Place - Cycle DevelopmentRanjeet Kumar
 
Awt Overview
Awt OverviewAwt Overview
Awt Overview
Fahruddin Arrazy
 
validation HPLC and HPTLC D-A star.pptx
validation HPLC and HPTLC D-A star.pptxvalidation HPLC and HPTLC D-A star.pptx
validation HPLC and HPTLC D-A star.pptx
DevaPundkar
 
Operation & Maintenance WTP.pptx
Operation & Maintenance WTP.pptxOperation & Maintenance WTP.pptx
Operation & Maintenance WTP.pptx
rony558517
 

Similar to Integrity Test Troubleshooting – Beyond Rewet and Retest (20)

Hplc troubleshooting converted
Hplc troubleshooting convertedHplc troubleshooting converted
Hplc troubleshooting converted
 
hplc class.ppt
hplc class.ppthplc class.ppt
hplc class.ppt
 
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNETItem 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
 
M epockete nf
M epockete nfM epockete nf
M epockete nf
 
Automating Leak Testing
Automating Leak TestingAutomating Leak Testing
Automating Leak Testing
 
Technology reqmts-hvac-design-ses-2-aseptic-wkshp-pune-f
Technology reqmts-hvac-design-ses-2-aseptic-wkshp-pune-fTechnology reqmts-hvac-design-ses-2-aseptic-wkshp-pune-f
Technology reqmts-hvac-design-ses-2-aseptic-wkshp-pune-f
 
07 wtp design 2
07 wtp design 207 wtp design 2
07 wtp design 2
 
Suncombe cip overview presentation
Suncombe cip overview presentationSuncombe cip overview presentation
Suncombe cip overview presentation
 
PPT-on-false-air.ppt
PPT-on-false-air.pptPPT-on-false-air.ppt
PPT-on-false-air.ppt
 
Final Review Elaine Mau Procter and Gamble
Final Review Elaine Mau Procter and GambleFinal Review Elaine Mau Procter and Gamble
Final Review Elaine Mau Procter and Gamble
 
Air Duct Leakage
Air Duct LeakageAir Duct Leakage
Air Duct Leakage
 
Hydrant flushing programs
Hydrant flushing programsHydrant flushing programs
Hydrant flushing programs
 
HVAC PPT.pptx
HVAC PPT.pptxHVAC PPT.pptx
HVAC PPT.pptx
 
validation-of-sterilising-and-virally-retentive-filters.pdf
validation-of-sterilising-and-virally-retentive-filters.pdfvalidation-of-sterilising-and-virally-retentive-filters.pdf
validation-of-sterilising-and-virally-retentive-filters.pdf
 
Troubleshooting of Distillation
Troubleshooting of DistillationTroubleshooting of Distillation
Troubleshooting of Distillation
 
Control valve presentation
Control valve presentationControl valve presentation
Control valve presentation
 
Clean In Place - Cycle Development
Clean In Place - Cycle DevelopmentClean In Place - Cycle Development
Clean In Place - Cycle Development
 
Awt Overview
Awt OverviewAwt Overview
Awt Overview
 
validation HPLC and HPTLC D-A star.pptx
validation HPLC and HPTLC D-A star.pptxvalidation HPLC and HPTLC D-A star.pptx
validation HPLC and HPTLC D-A star.pptx
 
Operation & Maintenance WTP.pptx
Operation & Maintenance WTP.pptxOperation & Maintenance WTP.pptx
Operation & Maintenance WTP.pptx
 

More from Merck Life Sciences

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
Merck Life Sciences
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
Merck Life Sciences
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
Merck Life Sciences
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
Merck Life Sciences
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
Merck Life Sciences
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Merck Life Sciences
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
Merck Life Sciences
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
Merck Life Sciences
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Merck Life Sciences
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Merck Life Sciences
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
Merck Life Sciences
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
Merck Life Sciences
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?
Merck Life Sciences
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Merck Life Sciences
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Merck Life Sciences
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Merck Life Sciences
 
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Merck Life Sciences
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
Merck Life Sciences
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
Merck Life Sciences
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
Merck Life Sciences
 

More from Merck Life Sciences (20)

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
 
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
 

Recently uploaded

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
BeshedaWedajo
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
aunty1x2
 
Anatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptxAnatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptx
shanicedivinagracia2
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Aboud Health Group
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
Nguyễn Thị Vân Anh
 
Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
LAB Sports Therapy
 
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
Nguyễn Thị Vân Anh
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 

Recently uploaded (20)

Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...Contact Now  89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
Contact Now 89011**83002 Dehradun ℂall Girls By Full Service ℂall Girl In De...
 
Anatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptxAnatomy and Physiology Chapter-16_Digestive-System.pptx
Anatomy and Physiology Chapter-16_Digestive-System.pptx
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
 
Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
 
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
VERIFICATION AND VALIDATION TOOLKIT Determining Performance Characteristics o...
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 

Integrity Test Troubleshooting – Beyond Rewet and Retest

  • 1. NOT FOR U.S. AND CANADA AUDIENCE Randy Wilkins Principal Technical Consultant
  • 2. 2 • “Retesting is just a routine part of the process” - The best option for troubleshooting is to not have to do it in the first place - Webinar: Filter Integrity Testing Best Practices http://bit.ly/2jEKlEm • “Filters always fail because they are not wet properly” - Poor wetting is a reason, but far from the only reason - Ignoring other potential failure modes result in lost time, product and frustration Integrity Testing Myths
  • 3. 3 • “Retesting is just a routine part of the process” - The best option for troubleshooting is to not have to do it in the first place - Webinar: Filter Integrity Testing Best Practices http://bit.ly/2jEKlEm • “Filters always fail because they are not wet properly” - Poor wetting is a reason, but far from the only reason - Ignoring other potential failure modes result in lost time, product and frustration • “You are only allowed to re-test the filter twice” - You can’t simply retest until you get the answer you want - Why impose a limit? - If the reason for a failed/invalid test is clear and documented, why limit the option for a re-test? Integrity Testing Myths
  • 4. 4 Demystifying Integrity Test Filters Understanding the possible causes of IT failures Being able to apply a logical step-by-step re-test procedure to distinguish between a false failure and a real failure Developing internal trouble shooting SOP to establish the root cause of IT failures After today’s session you will be able to improve your internal IT process by:
  • 5. 5 Integrity Test Review Integrity tests are based on capillary forces that hold liquid in the pores of wet membranes. Liquid in the pores of the membrane are a barrier to bulk gas flow. The smaller the pores, the stronger the capillary forces. 4 . k .  . cos  BP = ----------------- d • k = shape correction factor • = surface tension • = contact angle • d = pore diameter Bubble Point Test K . (P1 - P2) . A .  Diffusion = -------------------- L K = Diffusivity / Solubility coefficient P1, P2 = Pressure difference across the system = Membrane porosity L = Effective path length A = Membrane area Diffusion Test 5
  • 6. Integrity Test Review – Diffusion  Liquid is held in the pores of a fully wetted membrane filter by capillary forces  A pressure differential will give a gas concentration gradient across the filter.  Results in diffusive gas flow from upstream to downstream. Wet membrane Apply pressure from validated specification Hold pressure 6
  • 7. 7 Integrity Test Review - Diffusion Gas flow rate within specification indicates flow is solely from diffusion, which indicates the absence of defects or over sized pores. Out of specification GasFlow Within specification Pressure Bad filter Good filter Measure the gas flow rate
  • 8. Integrity Test Review – Bubble Point 8 Out of specification Within specification GasFlow Pressure Durapore® CVGL: 50psid Good filter Bad filter Wet Membrane  Water is held in the pores by capillary force Gradually raise pressure  Sufficient pressure will overcome capillary forces and push liquid from the filter Determine pressure were onset of bulk flow is observed  The smaller the pores, the higher the bubble point pressure
  • 9. Integrity Test Review – Automated Testing 9 All else being constant, the change in pressure can be used to determine the gas flow rate 1 During integrity testing gas molecules flow through the filter and leave the system 2 Fewer gas molecules upstream result in lower pressure 3 Upstream Pressurized Compressed gas Gas flow
  • 10. Potential Results – General Categories • What are potential results? 10-inch Durapore® filter specifications Bubble point ≥50 psi Diffusion ≤ 13.3 cc/min at 40 psi GasFlow Pressure Diffusion spec Bubble Point spec. 10
  • 11. Potential Results – General Categories GasFlow Pressure Diffusion spec Bubble Point spec. PASS • What are potential results? 10-inch Durapore® filter specifications Bubble point ≥50 psi Diffusion ≤ 13.3 cc/min at 40 psi Example 1 - PASS BP = 55 psi Diffusion = 10 cc/min 11
  • 12. Potential Results – General Categories • What are potential results? 10-inch Durapore® filter specifications Bubble point ≥50 psi Diffusion ≤ 13.3 cc/min at 40 psi Example 1 - PASS BP = 55 psi Diffusion = 10 cc/min Example 2 – Marginal Failure BP = 48 psi Diffusion = 20 cc/min GasFlow Pressure Diffusion spec Bubble Point spec. PASS Marginal failure 12
  • 13. Potential Results – General Categories • What are potential results? 10-inch Durapore® filter specifications Bubble point ≥50 psi Diffusion ≤ 13.3 cc/min at 40 psi Example 1 - PASS BP = 55 psi Diffusion = 10 cc/min Example 2 – Marginal Failure BP = 48 psi Diffusion = 20 cc/min Example 3 - Gross Failure BP < 5psi GasFlow Pressure Diffusion spec Bubble Point spec PASS Marginal failureGross failure 13
  • 14. Potential Results – General Categories • What are potential results? 10-inch Durapore® filter specifications Bubble point ≥50 psi Diffusion ≤ 13.3 cc/min at 40 psi Example 1 - PASS BP = 55 psi Diffusion = 10 cc/min Example 2 – Marginal Failure BP = 48 psi Diffusion = 20 cc/min Example 3 - Gross Failure BP < 5psi Example 4 - Invalid Test BP > 75 psi Diffusion = 0 cc/min GasFlow Pressure Diffusion spec Bubble Point spec. PASS Marginal failureGross failure Invalid 14
  • 15. A Good Troubleshooting SOP is Essential A well written, properly executed troubleshooting SOP should answer two questions: 1. Is the filter integral or not? 2. Why did the test fail in the first place? 15
  • 16. SOP Development – What can go wrong? Flow and Pressure Wetting Limits 0 10 20 30 40 50 60 0 0.2 0.4 0.6 0.8 1 Flow Rate (lpm/ft^2) Pressure(psi) INTEGRITY TEST PASS ZONE INTEGRITY TEST FALSE FAILURE ZONE Recommended Wetting Conditions 16 1. Poor wetting
  • 17. SOP Development – What can go wrong? 17 1. 2. Poor wetting Wrong test program
  • 18. SOP Development – What can go wrong? 18 1. 2. 3. Poor wetting Wrong test program Wrong filter used
  • 19. SOP Development – What can go wrong? 19 1. 2. 3. 4. Poor wetting Wrong test program Wrong filter used Improper seals
  • 20. SOP Development – What can go wrong? 20 1. 2. 3. 4. 5. Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter
  • 21. SOP Development – What can go wrong? 21 1. 2. 3. 4. 5. 6. Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid 4 . k .  . cos  BP = ------------------------- d • k = shape correction factor • = surface tension • = contact angle • d = pore diameter Bubble Point Test
  • 22. SOP Development – What can go wrong? 22 1. 2. 3. 4. 5. 6. 7. Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Wrong test gas K . (P1 - P2) . A .  Diffusion = --------------------- L K = Diffusivity / Solubility coefficient P1, P2 = Pressure difference across the system = Membrane porosity L = Effective path length A = Membrane area Diffusion Test
  • 23. SOP Development – What can go wrong? 23 z 1. 2. 3. 4. 5. 6. 7. 8. Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas
  • 24. SOP Development – What can go wrong? 24 z 1. 2. 3. 4. 5. 6. 7. 8. 9. Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change
  • 25. Stable Temperature Environment Manufacturers specifications are typically established at ambient temperature (~23°C) If operating outside of ambient temperature, a ratio should be established during validation and applied to test specification - e.g., Cold room operation or heat jacketed housing Effect of Tem perature on Diffusional Flow rate 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2 5 10 15 20 25 30 35 40 45 50 55 60 65 70 Tem perature (C) CorrectionFactor(Relative to23C) There is no significant impact on diffusive flow or BP over normal ambient temperature range 1 2 25
  • 26. Stable Temperature Environment Within Specification Out of Specification AirFlow ml/min Time min Test has to be repeated per retest SOP after establishing stable test conditions Apparent Gas Flow Trained operator can identify the temperature effect by reviewing the flow curve Common reasons for temperature changes  Inadequate stabilization after steaming or wetting with hot WFI  Environmental changes during testing near autoclave, HVAC outlets, cold room door, near a window, etc.  When using Automatic Testers, temperature changes during a test leads to additional upstream pressure gain or loss – Test Error  Idea Gas Law – PV=nRT  As Temperature increases, Pressure increases  As Temperature decreases, Pressure decreases  Even a change of 1 C DURING the test can lead to false failure because the pressure change WILL NOT be solely due to gas flow 26 Flow at unstable temp False failure Flow at stable temp
  • 27. SOP Development – What can go wrong? z 1. 2. 3. 4. 5. 6. 7. 8. 9. Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression 27 Common causes for surface tension suppression: Residual Product: Develop product based on integrity test specification and post-use flush procedure Application Note AN1505EN00
  • 28. SOP Development – What can go wrong? 28 z 1. 2. 3. 4. 5. 6. 7. 8. 9. 10 Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression Common causes for surface tension suppression: • Contaminants: New silicone tubing, residual cleaning agent, etc. - Identify and eliminate Freon residue - silicone rubber Millidisk minus body oil Silicone oil 100020003000 cm-¹
  • 29. SOP Development – What can go wrong? 29 z 1. 2. 3. 4. 5. 6. 7. 8. 9. 10 Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression Common causes for surface tension suppression: • Contaminants: New silicone tubing, residual cleaning agent, etc. - Identify and eliminate Impact of tubing material on the failure of product-specific bubble points of sterilizing grade-filters Meyer and Vargas, PDA Journal of Parenteral Science, Vol 60 n°4 2006
  • 30. SOP Development – What can go wrong? 30 z 1. 2. 3. 4. 5. 6. 7. 8. 9. 10 Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression 11. Damaged O-rings
  • 31. SOP Development – What can go wrong? 31 z 1. 2. 3. 4. 5. 6. 7. 8. 9. 10 Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression 11. 12. Damaged O-rings Instrument calibration
  • 32. SOP Development – What can go wrong? 32 z 1. 2. 3. 4. 5. 6. 7. 8. 9. 10 Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression 11. 12. 13. Damaged O-rings Instrument calibration Air lock
  • 33. SOP Development – What can go wrong? 33 z 1. 2. 3. 4. 5. 6. 7. 8. 9. 10 Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression 11. 12. 13. Damaged O-rings Instrument calibration Air lock NOTE: This is not an exhaustive list. Consider developing a site-specific list by conducting a brainstorming session with the people routinely performing the integrity test.
  • 34. SOP Development – What can go wrong? 34 Pass Fail Initial Test Wet at 1 LPM/0.1 m2 filter area
  • 35. SOP Development 35 z 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression 11. 12. 13. Damaged O-rings Instrument calibration Air lock Evaluate test results Verify system set-up and test parameters
  • 36. Evaluate Test Results 36 36 Stable flow Clear BP Good test Stable flow Shifted up Possible leak Non-stable flow Likely temp change
  • 37. Troubleshooting Flow Chart Development 37 Pass Set up or Execution problem identified and corrected Fail Initial Test Wet at 1 LPM/0.1 m2 filter area Check test set-up and execution Test set-up and execution verified correct
  • 38. SOP Development 38 z 1. 2. 3. 4. 5. 6. 7. 8. 9. 10 Poor wetting Wrong test program Wrong filter used Improper seals Damaged filter Wrong wetting fluid Leaks (housing, tubing, integrity tester) Wrong test gas Temperature change Surface tension suppression 11. 12. 13. Damaged O-rings Instrument calibration Air lock Remaining potential failure modes require re-test.
  • 39. Rewet Options Wetting Option Ease of Implementation Failure Modes Addressed Failure Modes Not Addressed Longer Time Easy Poor wetting, non-adsorbed surface active residuals Damage, Air Lock, adsorbed surface active contaminants Warm Water Flush Easy if facilities are available Poor wetting, non-adsorbed water soluble surface active residuals Damage, Air lock, adsorbed surface active residuals Higher Flow Rate Easy depending on system capabilities Poor wetting, non-adsorbed surface active residuals Damage, Air Lock, adsorbed surface active contaminants Higher System Pressure Easy Poor Wetting, non-adsorbed surface active residuals, Damage, Air lock, adsorbed surface active residuals Alcohol Complex when alcohol contamination in the process is a risk Poor wetting, non-adsorbed surface active residuals, adsorbed surface active residuals, Damage, severe air lock 39
  • 40. Pressure Wetting Standard Wetting inlet 0 outlet 2 For 0.22 m Durapore® filter devices at 1 lpm/0.1 m2 Inlet pressure = 2 psi/0.14 bar Outlet pressure = 0 psi/0 bar p = 2 psi/0.14 bar High Pressure Wetting inlet 38 outlet 40 High Pressure Wetting at 1 lpm/0.1 m2 Inlet pressure = 40 psi/2.7 bar Outlet pressure = 38 psi/2.6 bar p = 2 psi/0.14 bar 40
  • 41. Rewet Options Wetting Option Ease of Implementation Failure Modes Addressed Failure Modes Not Addressed Longer Time Easy Poor wetting, non-adsorbed surface active residuals Damage, Air Lock, adsorbed surface active contaminants Warm Water Flush Easy if facilities are available Poor wetting, non-adsorbed water soluble surface active residuals Damage, Air lock, adsorbed surface active residuals Higher Flow Rate Easy depending on system capabilities Poor wetting, non-adsorbed surface active residuals Damage, Air Lock, adsorbed surface active contaminants Higher System Pressure Easy Poor Wetting, non-adsorbed surface active residuals, Damage, Air lock, adsorbed surface active residuals Alcohol Complex when alcohol contamination in the process is a risk Poor wetting, non-adsorbed surface active residuals, adsorbed surface active residuals, Damage, severe air lock 41
  • 42. First Retest – High Pressure Wet inlet 38 outlet 40 42 Pass Consider poor wetting as cause of initial test failure Fail First Re-test Wet at 1 LPM/0.1 m2 filter area with back pressure
  • 43. Second Retest – Alcohol Wet 43 Pass Consider presence of surface active compounds as the cause of initial test failure Fail Second Re-test Wet and test with 70/30 IPA 43
  • 44. Third Retest – Dry and Re-wet with water 4444 Pass Initial failures likely due to air lock Fail Dry with dynamic air flow or oven drying at 80 C for 8 hrs Wet and test with water Contact filter vendor for confirmation and defect analysis
  • 45. Summary • When failing integrity test results occur, consider all the potential failure causes - Many are common, some may be site specific • Develop a troubleshooting flowchart based on understanding of failure modes and remedies • Conclusions about failure modes may not be definitive - A logical approach will yield the best assessment of failure mode - Best assessment will yield justification for re-tests and direction for corrective actions 45
  • 46. Additional TroubleshootingAdditional Troubleshooting - PDA 26 46 The 2008 revision includes an excellent trouble-shooting flowchart